Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond Surgical Margins: Fully Mature Tertiary Lymphoid Structures (fmTLSs) Are Predictive Biomarkers for Local Recurrence in Primary Soft-Tissue Sarcomas.

Cancers·2026
Same author

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors from Whole-Slide Images.

Cancer research·2026
Same author

Multi-omics profiling identified two epithelioid sarcoma molecular subtypes with distinct signaling and immune characteristics.

Cancer communications (London, England)·2025
Same author

Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas: A Secondary Analysis of a Randomized Clinical Trial.

JAMA network open·2025
Same author

Prognostic prediction in soft-tissue sarcomas using deep learning and digital pathology of tumor and margin areas.

Scientific reports·2025
Same author

Multimodal prediction of metastatic relapse using federated deep learning in soft-tissue sarcoma with a complex genomic profile.

Scientific reports·2025

Related Experiment Video

Updated: May 5, 2026

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

8.5K

[Sarcomas, example of a pathologist network organization].

Agnes Neuville1, Jean-Michel Coindre1

  • 1Université Victor-Ségalen, institut Bergonié, département de pathologie, laboratoire d'anatomie pathologie et Inserm U916, 229, cours de l'Argonne, 33076 Bordeaux Cédex, France.

Bulletin Du Cancer
|November 22, 2013
PubMed
Summary

A national pathology network improves sarcoma diagnosis and patient care. This systematic review enhances understanding and management of rare tumors like sarcomas, gastro-intestinal stromal tumors (GIST), and desmoid tumors.

Keywords:
diagnosispathologistssarcomassystematic histological review

More Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.2K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

3.1K

Related Experiment Videos

Last Updated: May 5, 2026

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

8.5K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.2K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

3.1K

Area of Science:

  • Oncology
  • Pathology
  • Medical Diagnostics

Context:

  • Sarcomas are rare, heterogeneous cancers presenting significant diagnostic challenges.
  • Accurate diagnosis of sarcoma, gastro-intestinal stromal tumors (GIST), and desmoid tumors is critical for effective treatment.
  • Existing diagnostic pathways may lack the necessary specialized review for these complex neoplasms.

Purpose:

  • To establish and evaluate a national network of pathologists for systematic histological review of sarcomas, GIST, and desmoid tumors.
  • To assess the impact of this centralized review on diagnostic accuracy and patient management.
  • To collect data and biological material for advancing the understanding of these rare tumors.

Summary:

  • A national network was created in 2009 for systematic histological review of all new sarcoma, GIST, and desmoid tumor cases.
  • The first two years of activity demonstrated significant benefits for both patients and pathologists.
  • The network facilitates improved diagnostic management and knowledge acquisition for these rare malignancies.

Impact:

  • Enhanced diagnostic accuracy for rare tumors, leading to more appropriate patient treatment.
  • Improved understanding of sarcoma, GIST, and desmoid tumor biology through data and material collection.
  • Establishment of better guidelines for the diagnostic management of these challenging cancers.